Cargando…

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran

Detalles Bibliográficos
Autores principales:	Ghafari, Mahan, Kadivar, Alireza, Katzourakis, Aris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906708/ https://www.ncbi.nlm.nih.gov/pubmed/33600759 http://dx.doi.org/10.1016/S1473-3099(21)00053-0

Ejemplares similares

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Nazemipour, Maryam, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
por: Darvishian, Maryam, et al.
Publicado: (2021)

Excess deaths associated with the Iranian COVID-19 epidemic: A province-level analysis
por: Ghafari, Mahan, et al.
Publicado: (2021)

A framework for reconstructing SARS-CoV-2 transmission dynamics using excess mortality data
por: Ghafari, Mahan, et al.
Publicado: (2022)

Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
por: Stringhini, Silvia, et al.
Publicado: (2021)

Kinetics and seroprevalence of SARS-CoV-2 antibodies in children
por: Roarty, Cathal, et al.
Publicado: (2021)

Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients
por: Del Zompo, Fabio, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence in Spain
por: George, Thukalan Paulose
Publicado: (2020)

SARS-CoV-2 seroprevalence in Spain
por: Hoffmann, Christian, et al.
Publicado: (2020)

Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors
por: Razafimahatratra, Solohery Lalaina, et al.
Publicado: (2021)

Seroprevalence and presentation of SARS-CoV-2 in pregnancy
por: Crovetto, Francesca, et al.
Publicado: (2020)

Purifying Selection Determines the Short-Term Time Dependency of Evolutionary Rates in SARS-CoV-2 and pH1N1 Influenza
por: Ghafari, Mahan, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 in Hong Kong returnees
por: Hanage, William P, et al.
Publicado: (2020)

SARS-CoV-2 seroprevalence in Spain – Authors' reply
por: Pollán, Marina, et al.
Publicado: (2020)

Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2
por: Dong, Qunfeng, et al.
Publicado: (2020)

Immunoassays for anti-SARS-CoV-2 antibodies: recent insights
por: Van Elslande, Jan, et al.
Publicado: (2021)

The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2
por: Pekar, Jonathan E., et al.
Publicado: (2023)

SeroTracker: a global SARS-CoV-2 seroprevalence dashboard
por: Arora, Rahul K, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 in Hong Kong returnees – Authors' reply
por: To, Kelvin Kai-Wang, et al.
Publicado: (2020)

Estimating the false-negative test probability of SARS-CoV-2 by RT-PCR
por: Wikramaratna, Paul S, et al.
Publicado: (2020)

SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline
por: Bolotin, Shelly, et al.
Publicado: (2021)

Probabilistic classification of anti‐SARS‐CoV‐2 antibody responses improves seroprevalence estimates
por: Castro Dopico, Xaquin, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India
por: Malani, Anup, et al.
Publicado: (2021)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

No crossreactivity of anti-SARS-CoV-2 spike protein antibodies with Syncytin-1
por: Prasad, Mukul, et al.
Publicado: (2021)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies
por: Choy, Kay Weng
Publicado: (2021)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
por: Ibarrondo, F. Javier, et al.
Publicado: (2020)

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products
por: Romero, Carolina, et al.
Publicado: (2021)

Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab
por: Antonelli, Guido, et al.
Publicado: (2021)

Correspondence on Body Weight, Anti-SARS-CoV-2 Antibody and mRNA Vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
por: Zheng, Ming, et al.
Publicado: (2020)

High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts
por: Naranbhai, Vivek, et al.
Publicado: (2020)

Seroprevalence of Anti-SARS-CoV-2 Antibodies in Benadir Region, Somalia
por: Adam, Mohamed Hussein, et al.
Publicado: (2022)

A mechanistic evolutionary model explains the time-dependent pattern of substitution rates in viruses
por: Ghafari, Mahan, et al.
Publicado: (2021)

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products—an update
por: Romero, Carolina, et al.
Publicado: (2022)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies – Authors' reply
por: Iversen, Kasper, et al.
Publicado: (2021)

The presence of SARS-CoV2 antibodies in MS patients
por: Wallach, Asya I., et al.
Publicado: (2021)

Air conditioning system usage and SARS-CoV-2 transmission dynamics in Iran
por: Pourkarim, Mahmoud Reza, et al.
Publicado: (2020)

Seroprevalence of anti-SARS-CoV2 Antibodies in Umbrian Persons Living with HIV
por: Papalini, Chiara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aecelcapf5il8o757mlbhvfdv6